Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200043077/composite

$

47.18

Change

-0.62 -1.30%

Volume

Volume 17,613

Oct 22, 2021, 7:37 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Previous close

$ 46.17

$ 47.80

Change

+1.63 +3.53%

Day low

Day high

$45.51

$47.89

Open
Open: 46.05

52 week low

52 week high

$39.09

$93.94

Open

Market cap

$5.81B

Average volume

484,321

P/E ratio

167.07

Rev. per Employee

$1.15M

EPS

0.29

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/dnli

MarketWatch News on DNLI

  1. Denali Therapeutics started at outperform with $85 stock price target at Oppenheimer

    7:16 a.m. Sept. 21, 2021

    - Tomi Kilgore

  2. Biogen's Alzheimer's Drug Is Approved by the FDA

    2:02 p.m. June 7, 2021

    - Barron's Online

  3. What to Know About the FDA's Approval of Biogen's Alzheimer's Drug

    10:47 a.m. June 8, 2021

    - Barron's Online

  4. Don’t Expect Amazon Prime Day to Move the Stock

    8:26 a.m. June 2, 2021

    - Barron's Online

  5. The FDA's Biogen Decision Will Cause Waves Across Biotech

    9:20 p.m. June 1, 2021

    - Barron's Online

  6. Denali Therapeutics started at buy with $70 stock price target at UBS

    9:03 a.m. May 18, 2021

    - Tomi Kilgore

  7. Biotech stocks are a buy — especially these 18 picks

    2:02 p.m. March 13, 2021

    - Michael Brush

  8. The 12 Most Overpriced Stocks in America

    8:48 a.m. Dec. 28, 2020

    - Barron's Online

  9. Denali down 10% on pause in neurological drug

    5:53 p.m. June 9, 2020

    - MarketWatch.com

  10. Panic Takes Hold

    8:39 p.m. March 12, 2020

    - Barron's Online

  11. Denali Therapeutics upgraded to outperform from neutral at Wedbush

    9:05 a.m. Feb. 28, 2020

    - Tomi Kilgore

  12. Denali Therapeutics started at hold with $26 stock price target at Stifel Nicolaus

    8:40 a.m. Feb. 19, 2020

    - Tomi Kilgore

  13. Denali Therapeutics started at neutral with $19 stock price target at Wedbush

    8:22 a.m. Sept. 26, 2019

    - Tomi Kilgore

  14. Denali Therapeutics started at buy with $35 stock price target at Instinet

    8:35 a.m. Sept. 13, 2019

    - Tomi Kilgore

  15. Jeffrey Epstein’s Investing Lagged Behind the Market

    1:23 p.m. July 17, 2019

    - Barron's Online

  16. Harry Boxer’s 4 stocks running on earnings

    2:42 p.m. March 14, 2019

    - Harry Boxer

  17. Denali Therapeutics started at market perform at Raymond James

    8:57 a.m. Nov. 30, 2018

    - Tomi Kilgore

  18. Denali Therapeutics started at buy with$26 stock fair value estimate at Janney

    9:56 a.m. Nov. 12, 2018

    - Tomi Kilgore

  19. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/dnli

Other News on DNLI

  1. Warning: DNLI is at high risk of performing badly

    4:39 a.m. Oct. 21, 2021

    - Seeking Alpha

  2. New Strong Sell Stocks for October 12th

    11:00 a.m. Oct. 12, 2021

    - Zacks.com

  3. Denali/Sanofi ALS candidate granted FDA Fast Track status

    4:18 p.m. Oct. 6, 2021

    - Seeking Alpha

  4. Warning: DNLI has been downgraded to Very Bearish

    4:34 a.m. Sept. 29, 2021

    - Seeking Alpha

  5. Denali Therapeutics names Katie Peng as chief commercial officer

    9:19 a.m. Sept. 27, 2021

    - Seeking Alpha

  6. Loading more headlines...
/news/pressrelease/company/us/dnli

Press Releases on DNLI

  1. FRP Tank Market to Witness Growth Acceleration During 2020-2025

    12:59 p.m. Aug. 31, 2021

    - Market Insight Reports

  2. FRP Tank Market to Experience Rebound in Sales post COVID-19

    7:09 a.m. Aug. 19, 2021

    - Market Insight Reports

  3. Senda Biosciences Announces Closing of $98 Million Series B Financing

    8:00 a.m. June 10, 2021

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.